HIGHLIGHTS
- who: Miriam Kristine Sandvik and collaborators from the Oncology and Medical Physics, Haukeland University Hospital, Department of Heart have published the research work: Endothelial dysfunction in ME/CFS patients, in the Journal: PLOS ONE
- what: This study investigated large-vessel and small-vessel endothelial function in patients with ME/CFS. The study was a substudy of the RituxME trial a national multicenter randomized doubleblind placebo-controlled phase III study on the effect of rituximab vs. placebo in ME/CFS patients in Flow-mediated dilation (FMD) and post-occlusive reactive hyperemia (PORH) was measured at baseline . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.